Afeyan's Moderna to Start Covid-19 Vaccine Supplies to Singapore by Year-End

The world-renowned Armenian entrepreneur Noubar Afeyan's company, Moderna Therapeutics, plans to begin supplying its own Covid-19 vaccine to Singapore by the end of the year. According to Armenpress, this was announced by the company's director, Stéphane Bancel.

"We expect to start the supply as early as December," Bancel stated. The exact number of vaccine doses to be shipped to Singapore has not yet been disclosed.

On November 16, Moderna announced that its coronavirus vaccine demonstrated an efficacy of about 95 percent.